Workflow
沐邦高科(603398) - 2020 Q1 - 季度财报
banbaobanbao(SH:603398)2020-04-29 16:00

Financial Performance - Operating revenue for the first quarter was RMB 87,876,971.81, representing a decrease of 37.41% year-on-year[12] - Net profit attributable to shareholders was RMB 7,613,844.54, down 67.94% from the same period last year[12] - Basic earnings per share decreased by 72.73% to RMB 0.03 from RMB 0.11 in the same period last year[12] - The company reported a significant decrease in net profit and operating revenue, indicating challenges in the current market environment[12] - The company's operating revenue for the reporting period was ¥87,876,971.81, a decrease of 37.41% compared to ¥140,406,762.61 in the previous period, primarily due to the impact of the pandemic[21] - The company reported a 95.26% decrease in other income, amounting to ¥192,784.01, down from ¥4,068,850.01, attributed to a reduction in government subsidies[23] - Total operating revenue for Q1 2020 was $87.88 million, a decrease of 37.4% compared to $140.41 million in Q1 2019[46] - Net profit for Q1 2020 was $7.61 million, a decline of 68.0% from $23.75 million in Q1 2019[48] - Total profit for Q1 2020 was $9.62 million, a decrease of 65.6% compared to $28.02 million in Q1 2019[48] Cash Flow - The net cash flow from operating activities was negative at RMB -10,412,025.22, a decline of 475.49% compared to the previous year[12] - Cash inflow from operating activities for Q1 2020 was 115,048,570.24 CNY, a decrease of 10.5% from 128,842,878.47 CNY in Q1 2019[56] - Cash outflow from operating activities totaled 125,460,595.46 CNY in Q1 2020, slightly down from 126,069,931.01 CNY in Q1 2019[56] - Net cash flow from operating activities was -10,412,025.22 CNY in Q1 2020, compared to a positive 2,772,947.46 CNY in Q1 2019[56] - Cash flow from investing activities resulted in a net outflow of -3,379,170.00 CNY in Q1 2020, compared to -838,974.16 CNY in Q1 2019[56] - Net cash flow from financing activities was -9,519,971.69 CNY in Q1 2020, worsening from -1,236,952.71 CNY in Q1 2019[58] Assets and Liabilities - Total assets at the end of the reporting period reached RMB 1,043,884,301.06, a slight increase of 0.37% compared to the end of the previous year[12] - The total number of shareholders at the end of the reporting period was 15,496[19] - The largest shareholder, Shantou Bangling Trading Co., Ltd., held 28.33% of the shares[19] - The company’s inventory increased to ¥163,050,323.76 from ¥147,105,517.24, indicating a rise in stock levels[31] - Total liabilities amounted to CNY 296,056,640.33, a decrease from CNY 299,836,413.31, showing a decline of about 0.93%[40] - Shareholders' equity reached CNY 747,827,660.73, up from CNY 740,213,816.19, marking an increase of approximately 1.07%[40] - The total current liabilities increased to CNY 184,864,430.11 from CNY 173,336,949.13, reflecting an increase of approximately 6.93%[42] - Non-current liabilities totaled CNY 84,270,126.34, slightly down from CNY 84,334,813.60, indicating a decrease of approximately 0.08%[40] Expenses - The company’s financial expenses increased by 65.60% to ¥1,435,510.92, compared to ¥866,835.79, due to higher bank loan interest[21] - Research and development expenses for Q1 2020 were $3.51 million, slightly down from $3.71 million in Q1 2019[46] - Financial expenses for Q1 2020 increased to $1.44 million from $0.87 million in Q1 2019[46] - Sales expenses for Q1 2020 were $7.08 million, a decrease of 35.5% from $11.04 million in Q1 2019[46] - Tax expenses for Q1 2020 were $0.48 million, down 59.9% from $1.19 million in Q1 2019[46] Government Support and Development - The company received government subsidies amounting to RMB 199,448.17 during the reporting period[13] - The company has successfully developed and certified medical protective goggles and masks, which are now being sold internationally[24] - The company is in the process of revising its non-public stock issuance plan, which has been submitted for regulatory review[27]